• Potomac Photonics
  • March 13, 2020

Potomac’s New InstaQuote Online System Leads Advanced Manufacturing at the Speed of Light

Potomac’s New InstaQuote Online System Leads Advanced Manufacturing at the Speed of Light

Speed is the hallmark of modern life, and has become even more important in getting innovative products to market.  With 24/7 communication worldwide and better resources available for entrepreneurs, staying ahead of the competition is more challenging than ever before.

With speed at the center of our customers’ concerns, Potomac has recently added the online InstaQuote system to our website in order to exponentially hasten our commitment to producing products quickly while maintaining great quality. We aim to accelerate the advanced manufacturing experience for product development of medical devices, microfluidics, microelectronics, pharmaceuticals, cancer treatments and so much more via the new InstaQuote capability.

Our in-house software development team listened to the needs of our customers and developed an exponentially faster, easier quoting process for standard micro-manufacturing processes. Potomac President and CEO Mike Adelstein reiterates, “We are a customer-centric company and are always listening to the needs of designers, engineers and entrepreneurs in the field. InstaQuote is our answer to the increased speeds required in today fast-paced world.”

InstaQuote’s most powerful feature is digital analysis of drawings that identifies any issues in the design.  Experience shows that a design flaw will slow down the process of getting a file into the manufacturing flow.  Consequently, InstaQuote’s immediate identification and feedback of problems eliminates bottlenecks and allows the designer to align files with operating parameters. Once designs are optimized the quote can be generated online and the manufacturing process begins.

The InstaQuote system defines parameters for which the fast quote can be instantly generated but of course more complex parts, subassemblies, or complete products can also be quoted with the same attention to speed by working iteratively with our in-house design experts. Potomac also has standard materials such as Kapton in stock, further reducing lead times to deliver parts.

Scaling from prototype to production relies heavily on a design methodology that optimizes the design both for the specific application and for the manufacturing process.  InstaQuote is a sure way to ensure your competitive advantage in the marketplace by radically speeding up your quoting process to be the best designs instantly into manufacturing production.

Take a test drive of InstaQuote here and see for yourself the fastest turnaround in the industry!

Other Posts

Microfluidics: The Evolution from PDMS to Thermoplastics for Enhanced Scalability and Cost-Effectiveness

In the ever-evolving realm of microfluidics, the pivot from traditional materials to advanced alternatives is becoming increasingly evident. These “labs-on-a-chip” devices, pivotal in biological research, diagnostics, and drug delivery, owe their efficacy to the careful selection of materials and manufacturing methodologies. Historically, Polydimethylsiloxane (PDMS) has dominated the microfluidic landscape. Its biocompatibility, flexibility, and innate transparency…

  • Mike Adelstein
  • August 11, 2023

Potomac Photonics: Advancements in Precision Manufacturing of Silicon Wafers

Silicon wafers serve as a fundamental component in various technologies, and Potomac Photonics is leading the charge in their manufacturing and optimization. This industry front-runner has made significant strides in refining techniques for precise feature creation and hole drilling in silicon wafers, which includes wafer dicing and detailed patterning for diverse applications. Central Role of…

  • Potomac Photonics
  • July 13, 2023

New FDA Drug-testing Guidelines Open Door for Use of Data 

Generated by Microfluidic Organ-On-A-Chip Devices For decades the U.S. Food and Drug Administration has depended upon results from animal trials to prove the safety and efficacy of pharmaceuticals. Yet the methodology is far from reliable. Only 10% of the drugs that move from animal testing to human clinical trials succeeds. Such low yields from a…

  • Potomac Photonics
  • May 12, 2023